Related Experiment Videos
Increased ventricular contractility is not sufficient for effective positive inotropic intervention
P F Binkley1, D B Van Fossen, G J Haas
1Department of Medicine, Ohio State University, Columbus 43210, USA.
Insights
Dobutamine, unlike dopamine, improves ventricular-vascular coupling in heart failure patients by enhancing aortic impedance and power transfer efficiency. This suggests specific drug properties are crucial for optimal cardiac function.
Area of Science:
- Cardiology
- Biomedical Engineering
- Pharmacology
Background:
- Positive inotropic agents augment myocardial contractility in heart failure.
- Vascular changes accompanying dobutamine improve power transfer, but the specificity of this response is unclear.
Purpose of the Study:
- To compare the effects of dobutamine and dopamine on ventricular-vascular coupling in congestive heart failure patients.
- To determine if vascular responses to inotropic agents are drug-specific.
Main Methods:
- Examined aortic input impedance spectrum in 15 congestive heart failure patients.
- Administered dobutamine and dopamine as positive inotropic interventions.
- Measured changes in characteristic aortic impedance, wave reflection, and power output.
Main Results:
- Dobutamine significantly reduced characteristic aortic impedance and wave reflection.
- Dopamine did not produce similar significant reductions in impedance parameters.
- Dopamine resulted in a greater increase in pulsatile power output, indicating diminished power transfer efficiency.
Conclusions:
- Optimal power transfer in heart failure requires specific vascular changes, not just increased contractility.
- Dobutamine's effects on aortic impedance suggest a drug-specific mechanism for improving ventricular-vascular coupling.
- Ventriculoarterial coupling is critical for efficient cardiac function in heart failure.
Abstract:
Positive inotropic intervention with dobutamine in patients with congestive heart failure is accompanied by complementary vascular changes, as measured by the aortic input impedance spectrum, that promote the efficient transfer of augmented myocardial contractile power. It is unknown whether this is a nonspecific response to increased ventricular contractility or is a function of the properties of the positive inotropic agent employed. Therefore, the influence of two different positive inotropic interventions, dobutamine and dopamine, on ventricular-vascular coupling was examined in 15 patients with congestive heart failure. Significant reductions in characteristic aortic impedance, wave reflection, and low-frequency impedance moduli were noted with dobutamine and were not seen with dopamine. Consequently, a significantly (P = 0.0008) greater increase in pulsatile, rather than steady-state, power output was noted with dopamine that was reflective of a significantly diminished efficiency of power transfer. Therefore, optimal transfer of increased ventricular contractile power in patients with congestive heart failure requires increases in large vessel compliance and complementary changes in ventriculoarterial coupling.